# A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours

> clinical trial · VERIFIED · 2026-08-11

Status: RECRUITING · Sponsor: Shanghai Henlius Biotech · Condition: mCRPC or Advanced/Metastatic Solid Tumors

- Company: Shanghai Henlius Biotech
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07533708

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.